High-mobility Group Box 1 Induces the Epithelial-mesenchymal Transition, Glycolytic Switch, and Mitochondrial Repression via Snail Activation
![]() |
Lee, Su Yeon
(Department of Molecular Biology, College of Natural Sciences, Pusan National University)
Ju, Min Kyung (Department of Molecular Biology, College of Natural Sciences, Pusan National University) Jeon, Hyun Min (Department of Molecular Biology, College of Natural Sciences, Pusan National University) Kim, Cho Hee (Department of Molecular Biology, College of Natural Sciences, Pusan National University) Park, Hye Gyeong (Nanobiotechnology Center, Pusan National University) Kang, Ho Sung (Department of Molecular Biology, College of Natural Sciences, Pusan National University) |
1 | Barnard, M. E., Boeke, C. E. and Tamimi, R. M. 2015. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim. Biophys. Acta. 1856, 73-85. |
2 | Boroughs, L. K. and DeBerardinis, R. J. 2015. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 17, 351-359. DOI |
3 | Gogvadze, V., Orrenius, S. and Zhivotovsky, B. 2008. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 18, 165-173. DOI |
4 | Gunasekaran, M. K., Virama-Latchoumy, A. L., Girard, A. C., Planesse, C., Guerin-Dubourg, A., Ottosson, L., Andersson, U., Cesari, M., Roche, R. and Hoareau, L. 2016. TLR4-dependant pro-inflammatory effects of HMGB1 on human adipocyte. Adipocyte 5, 384-388. DOI |
5 | Hanahan, D. and Weinberg, R. A. 2011. Hallmarks of cancer: the next generation. Cell 144, 646-674. DOI |
6 | Schulze, A. and Harris, A. L. 2012. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491, 364-373. DOI |
7 | Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Park, H. G., Han, S. I. and Kang, H. S. 2016. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch. Oncotarget 7, 7925-7939. DOI |
8 | Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Yoo, M. A., Park, H. G., Han, S. I. and Kang, H. S. 2015. Dlx-2 is implicated in TGF-beta- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation. Int. J. Oncol. 46, 1768-1780. DOI |
9 | Lee, S. Y., Jeon, H. M., Ju, M. K., Kim, C. H., Yoon, G., Han, S. I., Park, H. G. and Kang, H. S. 2012. Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism. Cancer Res. 72, 3607-3617. DOI |
10 | Sariban-Sohraby, S., Magrath, I. T. and Balaban, R. S. 1983. Comparison of energy metabolism in human normal and neoplastic (Burkitt's lymphoma) lymphoid cells. Cancer Res. 43, 4662-4664. |
11 | Skibinski, A. and Kuperwasser, C. 2015. The origin of breast tumor heterogeneity. Oncogene 34, 5309-5316. DOI |
12 | Hsu, P. P. and Sabatini, D. M. 2008. Cancer cell metabolism: Warburg and beyond. Cell 134, 703-707. DOI |
13 | Cairns, R. A., Harris, I. S. and Mak, T. W. 2011. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95. DOI |
14 | Chen, Y. C., Statt, S., Wu, R., Chang, H. T., Liao, J. W., Wang, C. N., Shyu, W. C. and Lee, C. C. 2016. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci. Rep. 6, 18815. DOI |
15 | Hay, N. 2016. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635-649. DOI |
16 | He, M., Kubo, H., Ishizawa, K., Hegab, A. E., Yamamoto, Y., Yamamoto, H. and Yamaya, M. 2007. The role of the receptor for advanced glycation end-products in lung fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1427-1436. DOI |
17 | Herrmann, P. C. and Herrmann, E. C. 2007. Oxygen metabolism and a potential role for cytochrome c oxidase in the Warburg effect. J. Bioenerg. Biomembr. 39, 247-250. DOI |
18 | Huang, R. and Zong, X. 2017. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression. Crit. Rev. Oncol. Hematol. 115, 13-22. DOI |
19 | Lee, S. Y., Ju, M. K., Jeon, H. M., Kim, C. H., Park, H. G. and Kang, H. S. 2017. The role of Phosphofructokinase-2/Fructose-2,6-bisphosphatase 2 (PFKFB2) in Wnt-induced epithelial-mesenchymal transition. J. Life Sci. 27, 1245-1255. DOI |
20 | Lee, S. Y., Jeong, E. K., Ju, M. K., Jeon, H. M., Kim, M. Y., Kim, C. H., Park, H. G., Han, S. I. and Kang, H. S. 2017. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol. Cancer 16, 10. DOI |
21 | Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I. and Kang, H. S. 2019. Reactive oxygen species induce epithelialmesenchymal transition, glycolytic switch, and mitochondrial repression through the Dlx2/Snail signaling pathways in MCF7 cells. Mol. Med. Rep. 20, 2339-2346. |
22 | Lynch, J., Nolan, S., Slattery, C., Feighery, R., Ryan, M. P. and McMorrow, T. 2010. High-mobility group box protein 1: a novel mediator of inflammatory-induced renal epithelial-mesenchymal transition. Am. J. Nephrol. 32, 590-602. DOI |
23 | Wang, Y., Shi, J., Chai, K., Ying, X. and Zhou, B. P. 2013. The role of snail in EMT and tumorigenesis. Curr. Cancer Drug Targets 13, 963-972. DOI |
24 | Tang, D., Kang, R., Zeh, H. J. 3rd. and Lotze, M. T. 2010. High-mobility group box 1 and cancer. Biochim. Biophys. Acta. 1799, 131-140. DOI |
25 | Vander Heiden, M. G. 2011. Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 10, 671-684. DOI |
26 | Vander Heiden, M. G., Cantley, L. C. and Thompson, C. B. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033. DOI |
27 | Yang, W., Xia, Y., Hawke, D., Li, X., Liang, J., Xing, D., Aldape, K., Hunter, T., Alfred Yung, W. K. and Lu, Z. 2012. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150, 685-696. DOI |
28 | Yao, H., He, G., Yan, S., Chen, C., Song, L., Rosol, T. J. and Deng, X. 2016. Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget 8, 1913-1924. DOI |
29 | Yoon, Y. S., Lee, J. H., Hwang, S. C., Choi, K. S. and Yoon, G. 2005. TGF beta1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene 24, 1895-1903. DOI |
30 | Conti, L., Lanzardo, S., Arigoni, M., Antonazzo, R., Radaelli, E., Cantarella, D., Calogero, R. A. and Cavallo, F. 2013. The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells. FASEB J. 27, 4731-4744. DOI |
31 | Dang, C. V. 2012. Links between metabolism and cancer. Genes Dev. 26, 877-890. DOI |
32 | De Craene, B. and Berx, G. 2013. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97-110. DOI |
33 | DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. and Thompson, C. B. 2008. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20. DOI |
34 | Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., Lorkiewicz, P., St Clair, D., Hung, M. C., Evers, B. M. and Zhou, B. P. 2013. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23, 316-331. DOI |
35 | Gaskell, H., Ge, X. and Nieto, N. 2018. High-mobility group Box-1 and liver disease. Hepatol. Commun. 2, 1005-1020. DOI |
36 | Gatenby, R. A. and Gillies, R. J. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899. DOI |
37 | Kroemer, G. 2006. Mitochondria in cancer. Oncogene 25, 4630-4632. DOI |
38 | Kang, R., Tang, D., Schapiro, N. E., Loux, T., Livesey, K. M., Billiar, T. R., Wang, H., Van Houten, B., Lotze, M. T. and Zeh, H. J. 2014. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 33, 567-577. DOI |
39 | Kang, R., Zhang, Q., Zeh, H. J. 3rd., Lotze, M. T. and Tang, D. 2013. HMGB1 in cancer: good, bad, or both? Clin. Cancer Res. 19, 4046-4057. DOI |
40 | Kim, C. H., Jeon, H. M., Lee, S. Y., Ju, M. K., Moon, J. Y., Park, H. G., Yoo, M. A., Choi, B. T., Yook, J. I., Lim, S. C., Han, S. I. and Kang, H. S. 2011. Implication of snail in metabolic stress-induced necrosis. PLoS One 6, e18000. DOI |
41 | Krysko, O., Love Aaes, T., Bachert, C., Vandenabeele, P. and Krysko, D. V. 2013. Many faces of DAMPs in cancer therapy. Cell Death Dis. 4, e631. DOI |
42 | Porporato, P. E., Payen, V. L., Perez-Escuredo, J., De Saedeleer, C. J., Danhier, P., Copetti, T., Dhup, S., Tardy, M., Vazeille, T., Bouzin, C., Feron, O., Michiels, C., Gallez, B. and Sonveaux, P. 2014. A mitochondrial switch promotes tumor metastasis. Cell Reports 8, 754-766. DOI |
43 | Palumbo, R., Sampaolesi, M., De Marchis, F., Tonlorenzi, R., Colombetti, S., Mondino, A., Cossu, G. and Bianchi, M. E. 2004. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164, 441-449. DOI |
44 | Pavlova, N. N. and Thompson, C. B. 2016. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27-47. DOI |
45 | Pecina, P., Houstkova, H., Hansikova, H., Zeman, J. and Houstek, J. 2004. Genetic defects of cytochrome c oxidase assembly. Physiol. Res. 53 Suppl 1, S213-223. |
46 | Yu, L. X., Yan, L., Yang, W., Wu, F. Q., Ling, Y., Chen, S. Z., Tang, L., Tan, Y. X., Cao, D., Wu, M. C., Yan, H. X. and Wang, H. Y. 2014. Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat. Commun. 5, 5256. DOI |
47 | Peinado, H., Olmeda, D. and Cano, A. 2007. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428. DOI |
48 | Pohl, S. G., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P. and Dharmarajan, A. 2017. Wnt signaling in triple-negative breast cancer. Oncogenesis 6, e310. DOI |
49 | Polyak, K. 2011. Heterogeneity in breast cancer. J. Clin. Invest. 121, 3786-3788. DOI |
50 | Puisieux, A., Brabletz, T. and Caramel, J. 2014. Oncogenic roles of EMT-inducing transcription factors. Nat. Cell Biol. 16, 488-494. DOI |
51 | Sanchez-Tillo, E., Liu, Y., de Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D. S., Dean, D. C., Castells, A. and Postigo, A. 2012. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol. Life Sci. 69, 3429-3456. DOI |
52 | Zhu, L., Li, X., Chen, Y., Fang, J. and Ge, Z. 2015. High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma. Cancer Lett. 357, 527-534. DOI |
53 | Yu, X., Ma, R., Wu, Y., Zhai, Y. and Li, S. 2018. Reciprocal regulation of metabolic reprogramming and epigenetic modifications in cancer. Front. Genet. 9, 394. DOI |
54 | Zhang, J., Shao, S., Han, D., Xu, Y., Jiao, D., Wu, J., Yang, F., Ge, Y., Shi, S., Li, Y., Wen, W. and Qin, W. 2018. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-kappaB signaling pathway. Int. J. Oncol. 53, 659-671. DOI |
55 | Zheng, H. and Kang, Y. 2014. Multilayer control of the EMT master regulators. Oncogene 33, 1755-1763. DOI |
![]() |